Clinical Trials Logo

Clinical Trial Summary

The present study examine the effects of an aerobic and strength training program on cardiorespiratory fitness in testicular cancer (TC) patients during chemotherapy. Half of the participants will receive the exercise program and the other half will receive one individual lifestyle counseling session. The investigators hypothesize that TC patients in the exercise group will have less reduction in cardiorespiratory fitness during chemotherapy treatment compared to patients in the control group.


Clinical Trial Description

Testicular cancer (TC) patients receiving chemotherapy often experience troublesome side-effects during and after treatment. Both aerobic and strength exercise have showed beneficial effects on side-effects during and after treatment in other cancer diagnosis. Knowledge of the effects of physical exercise during and after chemotherapy in TC patients is insufficient and studies are needed. The primary aim is to examine the effects of physical exercise on cardiorespiratory fitness in TC patients during chemotherapy. Secondary aims are to examine the effects of physical exercise on other secondary health outcomes during and three and twelve months after chemotherapy.

The present study is a randomized controlled trial comparing a tailored exercise program consisting of aerobic and strength training during chemotherapy to a control group receiving one individual lifestyle counseling session during the first chemotherapy cycle. The TC patients will be included and assessed before the first cycle of chemotherapy and further assigned to either a exercise group or a control group. The intervention will last for 9 or 12 weeks (depending on the number of bleomycin, etoposide, cisplatin (BEP)/etoposide, cisplatin (EP) cycles received) and it will consists of two-three one-hour sessions per week mostly supervised by a personal trainer. All variables will be assessed pre- and post-intervention, and at three and 12 months follow-up. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02577172
Study type Interventional
Source Oslo University Hospital
Contact
Status Terminated
Phase N/A
Start date November 2015
Completion date November 2016

See also
  Status Clinical Trial Phase
Completed NCT00231582 - High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II Phase 2
Terminated NCT02900248 - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Completed NCT03403777 - Avelumab in Refractory Testicular Germ Cell Cancer. Phase 2
Completed NCT02890030 - The Platinum Study Comparison Group
Recruiting NCT05264337 - Lymphedema After Urologic Surgery
Active, not recruiting NCT03426865 - Role of Axumin PET Scan in Germ Cell Tumor
Completed NCT00001270 - Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma Phase 1
Completed NCT02459132 - High-Intensity Aerobic Interval Training in Testicular Cancer Survivors N/A
Completed NCT06309732 - GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT) Phase 2
Terminated NCT02499952 - Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors Phase 2
Recruiting NCT02304575 - Quality of Life Among Testicular Cancer Survivors N/A
Withdrawn NCT02492360 - Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy N/A
Completed NCT04122430 - Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours
Recruiting NCT02229916 - Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS
Completed NCT02161692 - Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors Phase 2
Completed NCT02966509 - Engagement of Patients With Advanced Cancer N/A
Recruiting NCT02341989 - Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer Phase 3
Completed NCT05056688 - Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors N/A
Terminated NCT05229900 - A Study of SGN-ALPV in Advanced Solid Tumors Phase 1
Completed NCT00123773 - Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence Phase 2